Connect Biopharma Holdings Ltd
NASDAQ:CNTB

Watchlist Manager
Connect Biopharma Holdings Ltd Logo
Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Watchlist
Price: 0.9509 USD -4.19% Market Closed
Market Cap: 52.5m USD
Have any thoughts about
Connect Biopharma Holdings Ltd?
Write Note

Intrinsic Value

CNTB's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CNTB stock under the Base Case scenario is 0.3276 USD. Compared to the current market price of 0.9509 USD, Connect Biopharma Holdings Ltd is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CNTB Intrinsic Value
0.3276 USD
Overvaluation 66%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Connect Biopharma Holdings Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CNTB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CNTB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CNTB?
Bearish
Neutral
Bullish

Fundamental Analysis

0.9509 USD
-4.19%
-4.19%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Connect Biopharma Holdings Ltd
CN
Biotechnology
Market Cap
52.5m USD
IPO
Mar 19, 2021
Employees
108
China
Market Cap
52.5m USD
Industry
Biotechnology
IPO
Mar 19, 2021
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Connect Biopharma Holdings Ltd

Provide an overview of the primary business activities
of Connect Biopharma Holdings Ltd.

What unique competitive advantages
does Connect Biopharma Holdings Ltd hold over its rivals?

What risks and challenges
does Connect Biopharma Holdings Ltd face in the near future?

Summarize the latest earnings call
of Connect Biopharma Holdings Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Connect Biopharma Holdings Ltd.

Provide P/S
for Connect Biopharma Holdings Ltd.

Provide P/E
for Connect Biopharma Holdings Ltd.

Provide P/OCF
for Connect Biopharma Holdings Ltd.

Provide P/FCFE
for Connect Biopharma Holdings Ltd.

Provide P/B
for Connect Biopharma Holdings Ltd.

Provide EV/S
for Connect Biopharma Holdings Ltd.

Provide EV/GP
for Connect Biopharma Holdings Ltd.

Provide EV/EBITDA
for Connect Biopharma Holdings Ltd.

Provide EV/EBIT
for Connect Biopharma Holdings Ltd.

Provide EV/OCF
for Connect Biopharma Holdings Ltd.

Provide EV/FCFF
for Connect Biopharma Holdings Ltd.

Provide EV/IC
for Connect Biopharma Holdings Ltd.

Show me price targets
for Connect Biopharma Holdings Ltd made by professional analysts.

What are the Revenue projections
for Connect Biopharma Holdings Ltd?

How accurate were the past Revenue estimates
for Connect Biopharma Holdings Ltd?

What are the Net Income projections
for Connect Biopharma Holdings Ltd?

How accurate were the past Net Income estimates
for Connect Biopharma Holdings Ltd?

What are the EPS projections
for Connect Biopharma Holdings Ltd?

How accurate were the past EPS estimates
for Connect Biopharma Holdings Ltd?

What are the EBIT projections
for Connect Biopharma Holdings Ltd?

How accurate were the past EBIT estimates
for Connect Biopharma Holdings Ltd?

Compare the revenue forecasts
for Connect Biopharma Holdings Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Connect Biopharma Holdings Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Connect Biopharma Holdings Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Connect Biopharma Holdings Ltd compared to its peers.

Compare the P/E ratios
of Connect Biopharma Holdings Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Connect Biopharma Holdings Ltd with its peers.

Analyze the financial leverage
of Connect Biopharma Holdings Ltd compared to its main competitors.

Show all profitability ratios
for Connect Biopharma Holdings Ltd.

Provide ROE
for Connect Biopharma Holdings Ltd.

Provide ROA
for Connect Biopharma Holdings Ltd.

Provide ROIC
for Connect Biopharma Holdings Ltd.

Provide ROCE
for Connect Biopharma Holdings Ltd.

Provide Gross Margin
for Connect Biopharma Holdings Ltd.

Provide Operating Margin
for Connect Biopharma Holdings Ltd.

Provide Net Margin
for Connect Biopharma Holdings Ltd.

Provide FCF Margin
for Connect Biopharma Holdings Ltd.

Show all solvency ratios
for Connect Biopharma Holdings Ltd.

Provide D/E Ratio
for Connect Biopharma Holdings Ltd.

Provide D/A Ratio
for Connect Biopharma Holdings Ltd.

Provide Interest Coverage Ratio
for Connect Biopharma Holdings Ltd.

Provide Altman Z-Score Ratio
for Connect Biopharma Holdings Ltd.

Provide Quick Ratio
for Connect Biopharma Holdings Ltd.

Provide Current Ratio
for Connect Biopharma Holdings Ltd.

Provide Cash Ratio
for Connect Biopharma Holdings Ltd.

What is the historical Revenue growth
over the last 5 years for Connect Biopharma Holdings Ltd?

What is the historical Net Income growth
over the last 5 years for Connect Biopharma Holdings Ltd?

What is the current Free Cash Flow
of Connect Biopharma Holdings Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Connect Biopharma Holdings Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Connect Biopharma Holdings Ltd

Balance Sheet Decomposition
Connect Biopharma Holdings Ltd

Current Assets 121m
Cash & Short-Term Investments 118.7m
Other Current Assets 2.3m
Non-Current Assets 4.9m
PP&E 4.7m
Intangibles 62k
Other Non-Current Assets 132k
Current Liabilities 24.3m
Accounts Payable 7.7m
Accrued Liabilities 2.6m
Other Current Liabilities 14m
Non-Current Liabilities 585k
Long-Term Debt 180k
Other Non-Current Liabilities 405k
Efficiency

Earnings Waterfall
Connect Biopharma Holdings Ltd

Revenue
0 CNY
Operating Expenses
-64.9m CNY
Operating Income
-64.9m CNY
Other Expenses
5.4m CNY
Net Income
-59.5m CNY

Free Cash Flow Analysis
Connect Biopharma Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CNTB Profitability Score
Profitability Due Diligence

Connect Biopharma Holdings Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROIC
Negative Free Cash Flow
Negative Operating Income
49/100
Profitability
Score

Connect Biopharma Holdings Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

CNTB Solvency Score
Solvency Due Diligence

Connect Biopharma Holdings Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
67/100
Solvency
Score

Connect Biopharma Holdings Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNTB Price Targets Summary
Connect Biopharma Holdings Ltd

Wall Street analysts forecast CNTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTB is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
537% Upside
Average
Price Target
7.14 USD
651% Upside
Highest
Price Target
8.4 USD
783% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CNTB?

Click here to dive deeper.

Dividends

Connect Biopharma Holdings Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CNTB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one CNTB stock?

The intrinsic value of one CNTB stock under the Base Case scenario is 0.3276 USD.

Is CNTB stock undervalued or overvalued?

Compared to the current market price of 0.9509 USD, Connect Biopharma Holdings Ltd is Overvalued by 66%.

Back to Top